GFPC
NVO

Global Financial Private Capital’s Novo Nordisk NVO Stock Holding History

Global Financial Private Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$75K Buy
2,302
+72
+3% +$2.3K ﹤0.01% 258
2020
Q1 		$68K Sell
2,230
-274
-11% -$8.16K ﹤0.01% 257
2019
Q4 		$72K Buy
+2,504
New +$69.3K ﹤0.01% 285

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Global Financial Private Capital's NVO Position: Q2 2020 in Review

Global Financial Private Capital increased its Novo Nordisk (NVO) stake by 3.2% in Q2 2020, buying an estimated $2.3K and bringing the position to 2,302 shares worth $75K. The position accounts for ﹤0.01% of the portfolio, ranked #258.

Global Financial Private Capital first reported a position in NVO in Q4 2019 and has held it in 3 quarters since. 661 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

  • Global Financial Private Capital held 2,302 shares of Novo Nordisk worth $75K as of Q2 2020.
  • Global Financial Private Capital bought 72 Novo Nordisk shares in Q2 2020, an estimated $2.3K.
  • Novo Nordisk made up ﹤0.01% of Global Financial Private Capital's portfolio in Q2 2020, its #258 holding.
  • Global Financial Private Capital first reported a position in Novo Nordisk in Q4 2019 and has held it in 3 quarters since.
  • 661 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.